Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 04, 2018

Hardy v. Mabvax Therapeutics Holdings et al

Track this case

Case Number:

3:18-cv-01160

Court:

California Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Cynthia Bashant

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 05, 2018

    SEC Probe Into Biotech Co. Made Shares Drop, Investor Says

    An investor in the biotechnology company Mabvax Therapeutics Holdings lodged a proposed class action in California federal court Monday, alleging the company's failure to disclose control issues and improper influence by some investors sparked a U.S. Securities and Exchange Commission investigation that caused its stock price to plummet.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login